Among patients with obsessive-compulsive disorder (OCD) adding cognitive-behavioral therapy to serotonin reuptake inhibitors (SRIs) was associated with greater reduction in symptoms and improvement in functioning and quality of life compared with adding an antipsychotic or placebo, according to a report published by JAMA Psychiatry, a JAMA Network publication...